Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Therapy in Vasospastic Angina
NCT02790528Phase 4Withdrawn
- Start
- Jul 2017
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in vasospastic angina (VSA) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: The Composite Event of all-cause death, myocardial infarction, angina-related hospitalization at 3 years. Planned start Jul 2017; status: withdrawn.
02
Drugs
atorvastatin
03
Conditions
vasospastic angina (VSA)
Beyond the preview
Go deeper on NCT02790528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790528.